Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach (Group Two Closed to Accrual as of 9/19/2006)
This study is ongoing, but not recruiting participants.
Study NCT00061932
Information provided by National Cancer Institute (NCI)
First Received: June 5, 2003
Last Updated: July 23, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
